Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer by Jiyun Lee, Zofia Piotrowska, Ross Soo, Byoung Chul Cho, Sun Min Lim

Get full text

Advances in the management of non-small-cell lung cancer harbouring exon 20 insertion mutations by Jia Li Low, Sun Min Lim, Jii Bum Lee, Byoung Chul Cho, Ross A Soo

Get full text

Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response by Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim, Nak-Jung Kwon

Get full text

Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-... by Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim

Get full text

Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report by Sangho Nam, MD, Sun Min Lim, MD, PhD, Byoung Chul Cho, MD, PhD, Jii Bum Lee, MD

Get full text

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma by Ahreum Kim, Ahreum Kim, Sun Min Lim, Joo-Hang Kim, Joo-Hang Kim, Jeong-Sun Seo, Jeong-Sun Seo

Get full text

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma by Ji Hyun Lee, Seong Gu Heo, Beung‐Chul Ahn, Min Hee Hong, Byoung Chul Cho, Sun Min Lim, Hye Ryun Kim

Get full text

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges by Yun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim

Get full text

Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme. by Sun Min Lim, Junjeong Choi, Jong Hee Chang, Jinyoung Sohn, Kristine Jacobson, Frank Policht, John Schulz, Byoung Chul Cho, Se Hoon Kim

Get full text

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea by Beung-Chul Ahn, Seoyoung Lee, Jiyun Lee, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Suyog Jain, Steve Olsen, Byoung Chul Cho

Get full text

Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer by Min Jung Geum, Chungsoo Kim, Ji Eun Kang, Jae Hee Choi, Jae Song Kim, Eun Sun Son, Sun Min Lim, Sandy Jeong Rhie

Get full text

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution. by Hyung Soon Park, Sun Min Lim, Sora Kim, Sangwoo Kim, Hye Ryun Kim, KyuBum Kwack, Min Goo Lee, Joo-Hang Kim, Yong Wha Moon

Get full text

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice by Byoung Chul Cho, Herbert H. F. Loong, Chun-Ming Tsai, Man Lung P. Teo, Hye Ryun Kim, Sun Min Lim, Suyog Jain, Steve Olsen, Keunchil Park

Get full text

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib by Sun Min Lim, MD, PhD, San-Duk Yang, PhD, Sangbin Lim, PhD, Hyo Sup Shim, MD, PhD, Byoung Chul Cho, MD, PhD

Get full text

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models by Sun Min Lim, San-Duk Yang, Sangbin Lim, Seong Gu Heo, Stetson Daniel, Aleksandra Markovets, Rafati Minoo, Kyoung-Ho Pyo, Mi Ran Yun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Get full text

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12) by Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong

Get full text

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy by Jii Bum Lee, Hyung Soon Park, Su Jin Choi, Seong Gu Heo, Ho Jung An, Hye Ryun Kim, Min Hee Hong, Sun Min Lim, Kyle Chang, Katie Quinn, Justin Odegaard, Byoung Yong Shim, Byoung Chul Cho

Get full text

Predicting treatment outcomes using F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy by Chang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, Hong In Yoon, Hyo Sup Shim, Ji Hyun Lee, Yejeong Han, Beung-Chul Ahn, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Arthur Cho, Sun Min Lim

Get full text

Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing. by Seul Lee, Yunjoo Joo, Eun Ji Lee, Youngseon Byeon, Jae-Hwan Kim, Kyoung-Ho Pyo, Young Seob Kim, Sun Min Lim, Peter Kilbride, Rohin K Iyer, Mingming Li, Mandy C French, Jung-Yub Lee, Jeeheon Kang, Hyesin Byun, Byoung Chul Cho

Get full text

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial by Sun Min Lim, Solange Peters, Ana Laura Ortega Granados, Gustavo dix Junqueira Pinto, Christian Sebastián Fuentes, Giuseppe Lo Russo, Michael Schenker, Jin Seok Ahn, Martin Reck, Zsolt Szijgyarto, Neda Huseinovic, Eleftherios Zografos, Elena Buss, Neda Stjepanovic, Sean O’Donnell, Filippo de Marinis

Get full text